Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maria Jamela Revilleza is active.

Publication


Featured researches published by Maria Jamela Revilleza.


BioMed Research International | 2011

How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance.

Maria Jamela Revilleza; Rui Wang; Janet Mans; Manqing Hong; Kannan Natarajan; David H. Margulies

Natural killer (NK) cells provide an initial host immune response to infection by many viral pathogens. Consequently, the viruses have evolved mechanisms to attenuate the host response, leading to improved viral fitness. One mechanism employed by members of the β-herpesvirus family, which includes the cytomegaloviruses, is to modulate the expression of cell surface ligands recognized by NK cell activation molecules. A novel set of cytomegalovirus (CMV) genes, exemplified by the mouse m145 family, encode molecules that have structural and functional features similar to those of host major histocompatibility-encoded (MHC) class I molecules, some of which are known to contribute to immune evasion. In this review, we explore the function, structure, and evolution of MHC-I-like molecules of the CMVs and speculate on the dynamic development of novel immunoevasive functions based on the MHC-I protein fold.


Journal of Immunology | 2012

The Peptide-Receptive Transition State of MHC Class I Molecules: Insight from Structure and Molecular Dynamics

Michael G. Mage; Michael A. Dolan; Rui Wang; Lisa F. Boyd; Maria Jamela Revilleza; Howard Robinson; Kannan Natarajan; Nancy B. Myers; Ted H. Hansen; David H. Margulies

MHC class I (MHC-I) proteins of the adaptive immune system require antigenic peptides for maintenance of mature conformation and immune function via specific recognition by MHC-I–restricted CD8+ T lymphocytes. New MHC-I molecules in the endoplasmic reticulum are held by chaperones in a peptide-receptive (PR) transition state pending release by tightly binding peptides. In this study, we show, by crystallographic, docking, and molecular dynamics methods, dramatic movement of a hinged unit containing a conserved 310 helix that flips from an exposed “open” position in the PR transition state to a “closed” position with buried hydrophobic side chains in the peptide-loaded mature molecule. Crystallography of hinged unit residues 46–53 of murine H-2Ld MHC-I H chain, complexed with mAb 64-3-7, demonstrates solvent exposure of these residues in the PR conformation. Docking and molecular dynamics predict how this segment moves to help form the A and B pockets crucial for the tight peptide binding needed for stability of the mature peptide-loaded conformation, chaperone dissociation, and Ag presentation.


Proceedings of the National Academy of Sciences of the United States of America | 2012

Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasion

Rui Wang; Kannan Natarajan; Maria Jamela Revilleza; Lisa F. Boyd; Li Zhi; Huaying Zhao; Howard Robinson; David H. Margulies

Natural killer (NK) cells are activated by engagement of the NKG2D receptor with ligands on target cells stressed by infection or tumorigenesis. Several human and rodent cytomegalovirus (CMV) immunoevasins down-regulate surface expression of NKG2D ligands. The mouse CMV MHC class I (MHC-I)–like m152/gp40 glycoprotein down-regulates retinoic acid early inducible-1 (RAE1) NKG2D ligands as well as host MHC-I. Here we describe the crystal structure of an m152/RAE1γ complex and confirm the intermolecular contacts by mutagenesis. m152 interacts in a pincer-like manner with two sites on the α1 and α2 helices of RAE1 reminiscent of the NKG2D interaction with RAE1. This structure of an MHC-I–like immunoevasin/MHC-I–like ligand complex explains the binding specificity of m152 for RAE1 and allows modeling of the interaction of m152 with classical MHC-I and of related viral immunoevasins.


European Journal of Immunology | 2008

Availability of autoantigenic epitopes controls phenotype, severity, and penetrance in TCR Tg autoimmune gastritis

Ditza Levin; Richard J. DiPaolo; Carine Brinster; Maria Jamela Revilleza; Lisa F. Boyd; Luc Teyton; Kannan Natarajan; Michael G. Mage; Ethan M. Shevach; David H. Margulies

We examined TCR:MHC/peptide interactions and in vivo epitope availability to explore the Th1‐ or Th2‐like phenotype of autoimmune disease in two TCR Tg mouse models of autoimmune gastritis (AIG). The TCR of strains A23 and A51 recognize distinct IAd‐restricted peptides from the gastric parietal cell H/K‐ATPase. Both peptides form extremely stable MHC/peptide (MHC/p) complexes. All A23 animals develop a Th1‐like aggressive, inflammatory AIG early in life, while A51 mice develop indolent Th2‐like AIG at 6–8 wk with incomplete penetrance. A51 T cells were more sensitive than A23 to low doses of soluble antigen and to MHC/p complexes. Staining with IAd/peptide tetramers was only detectable on previously activated T cells from A51. Thus, despite inducing a milder AIG, the A51 TCR displays a higher avidity for its cognate IAd/peptide. Nonetheless, in vivo proliferation of adoptively transferred A51 CFSE‐labeled T cells in the gastric lymph node was relatively poor compared with A23 T cells. Also, DC from WT gastric lymph node, presenting processed antigen available in vivo, stimulated proliferation of A23 T cells better than A51. Thus, the autoimmune potential of these TCR in their respective Tg lines is strongly influenced by the availability of the peptide epitope, rather than by differential avidity for their respective MHC/p complexes.


Immunologic Research | 2009

Structure and function of murine cytomegalovirus MHC-I-like molecules : how the virus turned the host defense to its advantage

Janet Mans; Li Zhi; Maria Jamela Revilleza; Lee M. Smith; Alec J. Redwood; Kannan Natarajan; David H. Margulies


Molecular Immunology | 2013

A structural and molecular dynamics approach to understanding the peptide-receptive transition state of MHC-I molecules☆

Michael G. Mage; Michael A. Dolan; Rui Wang; Lisa F. Boyd; Maria Jamela Revilleza; Howard Robinson; Kannan Natarajan; Nancy B. Myers; Ted H. Hansen; David H. Margulies


Journal of Immunology | 2014

Mouse cytomegalovirus glycoprotein m153 binds a dendritic cell-surface ligand (VIR5P.1026)

Mulualem Tilahun; Maria Jamela Revilleza; Janet Mans; Kannan Natarajan; David H. Margulies


Archive | 2012

Structure and Molecular Dynamics MHC Class I Molecules: Insight from The Peptide-Receptive Transition State of

Nancy B. Myers; Ted H. Hansen; Maria Jamela Revilleza; Howard Robinson; Michael G. Mage; Michael A. Dolan; Rui Wang; F Lisa


Molecular Immunology | 2012

The peptide-receptive transition state of MHC-I molecules: Insight from structure and molecular dynamics

Michael G. Mage; Michael A. Dolan; Rui Wang; Lisa F. Boyd; Maria Jamela Revilleza; Howard Robinson; Kannan Natarajan; Nancy B. Myers; Ted H. Hansen; David H. Margulies


Journal of Immunology | 2012

Functional and structural basis of T cell recognition in autoimmune gastritis: mapping of autoantigenic peptides of the {alpha}-chain of the H/K ATPase and X-ray structure of the I-Ad/peptide complexes

Maria Jamela Revilleza; Ditza Levin; Michael G. Mage; Sophie Candon; Kannan Natarajan; Wang Rui; Luc Teyton; Howard Robinson; Ethan M. Shevach; David H. Margulies

Collaboration


Dive into the Maria Jamela Revilleza's collaboration.

Top Co-Authors

Avatar

Kannan Natarajan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

David H. Margulies

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Michael G. Mage

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Lisa F. Boyd

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Howard Robinson

Brookhaven National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Rui Wang

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ditza Levin

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ethan M. Shevach

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ted H. Hansen

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Janet Mans

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge